Illicit Cannabis Activity Drops in States with Adult-Use Legalization, CU Study Finds

NEW YORK – A new analysis from Columbia University’s Mailman School of Public Health shows that states moving beyond medical Cannabis legalization to allow recreational use saw a sharp decline in law enforcement seizures of the drug, offering fresh evidence on how policy changes affect underground supply chains.

The survey, published in the International Journal of Drug Policy, stands out as one of the first to track illegal Cannabis activity through actual seizure records rather than surveys or sales estimates. Researchers examined 286,844 Cannabis seizures reported by agencies in the High Intensity Drug Trafficking Areas program across all 50 states and the District of Columbia from 2010 to 2023.

Using statistical models that accounted for population shifts, policing resources, and broader time trends, the team found that states adopting recreational Cannabis laws experienced a 45% reduction in average seizure counts compared with states that had only medical programs. The drop showed up right after the laws took effect and held steady a year later.

Nicole Fitzgerald, the study’s lead author and a postdoctoral fellow in epidemiology at Columbia Mailman, said the numbers suggest consumers may be turning to regulated outlets and that some unlicensed operators could be leaving the business. At the same time, she noted another factor at play: police departments in legalized states might simply be devoting less effort to Cannabis cases and more to harder drugs like fentanyl.

“Illegal Cannabis markets have not disappeared entirely in states with recreational legalization,” Fitzgerald said in the university’s release, “but the findings suggest that regulated markets may be displacing part of the illegal supply.”

Silvia Martins, professor of epidemiology and senior author, added that the results add to a limited body of work on how Cannabis rules shape black-market behavior. She called for follow-up studies to look at enforcement priorities, the number of licensed stores, and the actual volume of product seized rather than just the count of incidents.

As of last year, 24 states plus the District of Columbia had legalized recreational Cannabis, while medical programs existed in 40 states and the District. Cannabis itself remains classified as a Schedule I drug at the federal level, creating a patchwork that continues to influence both legal and underground operations.

The Columbia team stressed that seizure data serve as a useful but imperfect proxy. A reduction could reflect smaller illegal supplies, changed police focus, or both. Either way, the data provide state lawmakers and regulators with concrete numbers to weigh when considering whether to expand access or tighten oversight.

Wrapping up, these results bring a measured perspective to the ongoing debate. Regulated markets appear to be claiming measurable ground from illicit channels in states that have gone all the way to adult-use legalization. Yet the persistence of seizures even after policy shifts reminds everyone that taxes, licensing costs, and product availability still determine how quickly that transition happens. As more states review their approaches, this kind of granular evidence from law-enforcement records will help separate rhetoric from reality in building markets that work for operators, consumers, and public safety.

Image: norml.org